Search Results - "van den Hoek, A.M."

The CCR2 inhibitor propagermanium attenuates diet-induced insulin resistance, adipose tissue inflammation and nonalcoholic steatohepatitis by Mulder, P, Van Koppen, A, van den Hoek, A.M, Kleemann, R

Get full text

MON-P095: Preclinical Studies on Innovative Clinical Nutrition by Strijker, R, Van den Hoek, A.M, Kleemann, R, Rietman, A, Zondag, G

Get full text

Systems biology approach to identify processes and early markers for fibrosis in metabolically-induced non-alcoholic steatosis hepatitis in mice by Van Koppen, A, Verschuren, L, Nagabukuro, H, Costessi, A, Caspers, M, Morrison, M, Salic, K, Stoop, R, Turner, S.M, Li, K, Beysen, C, Hanauer, G, van den Hoek, A.M, Kleemann, R, Hanemaaijer, R

Get full text

Alirocumab, monoclonal antibody to PCSK9, dose-dependently decreases atherosclerosis, improves plaque stability and shows additive effects with atorvastatin in apoe3leiden.cetp mice by Van der Hoorn, J.W.A, Kühnast, S, Pieterman, E.J, Van den Hoek, A.M, Sasiela, W.J, Gusarova, V, Peyman, A, Schaefer, H.L, Schwahn, U, Jukema, J.W, Princen, H.M.G

Get full text

P238 METABOLICALLY INDUCED LIVER INFLAMMATION PROMOTES NASH DEVELOPMENT AND DIFFERS FROM ENDOTOXIN- AND CYTOKINE-INDUCED INFLAMMATION by Liang, W, Lindeman, J.H, Menke, A, Koonen, D, Wielinga, P.Y, Morrison, M, Mulder, P, Havekes, L.A.M, van den Hoek, A.M, Kleemann, R

Get full text

1273 OBESITY-INDUCED NAFLD: IDENTIFICATION OF TRANSCRIPTIONAL MASTER REGULATORS CONTROLLING METABOLIC AND INFLAMMATORY RESPONSES TO HIGH FAT DIET IN LIVER AND ADIPOSE TISSUE by Liang, W, Tonini, G, Mulder, P, van Erk, M, Kelder, T, van den Hoek, A.M, Mariman, R, Wielinga, P.Y, Baccini, M, Biggeri, A, Kleemann, R

Get full text

Atorvastatin attenuates diet-induced non-alcoholic steatohepatitis in ApoE3-Leiden mice by reducing hepatic inflammation by Inia, J.A., Van Den Hoek, A.M., Stokman, G., Pieterman, E.J., Morrison, M.C., Jukema, W.J., Princen, H.M.G.

Get full text

Efficacy of a novel PCSK9 inhibitory peptide alone and in combination with an anti-ANGPTL3 monoclonal antibody in a mouse model of atherosclerosis by Rolin, B., Princen, H.M.G., Van Den Hoek, A.M., Rakipovski, G., Lau, J.F., Garibay, P.W., Mogensen, C.K.

Get full text

Unraveling the transcriptional dynamics of NASH pathogenesis affecting atherosclerosis development by Van Den Hoek, A.M., Özsezen, S., Caspers, M.P.M., Van Koppen, A., Hanemaaijer, R., Verschuren, L.

Get full text

SAT-343 - The CCR2 inhibitor propagermanium attenuates diet-induced insulin resistance, adipose tissue inflammation and nonalcoholic steatohepatitis by Mulder, P., Van Koppen, A., van den Hoek, A.M., Kleemann, R.

Get full text

Variable cartilage degradation in mice with diet-induced metabolic dysfunction: food for thought by Kozijn, A.E., Gierman, L.M., van der Ham, F., Mulder, P., Morrison, M.C., Kühnast, S., van der Heijden, R.A., Stavro, P.M., van Koppen, A., Pieterman, E.J., van den Hoek, A.M., Kleemann, R., Princen, H.M.G., Mastbergen, S.C., Lafeber, F.P.J.G., Zuurmond, A.-M., Bobeldijk, I., Weinans, H., Stoop, R.

“…Human cohort studies have demonstrated a role for systemic metabolic dysfunction in osteoarthritis (OA) pathogenesis in obese patients. To explore the…”
Get full text

SAT-344 - Systems biology approach to identify processes and early markers for fibrosis in metabolically-induced non-alcoholic steatosis hepatitis in mice by Van Koppen, A., Verschuren, L., Nagabukuro, H., Costessi, A., Caspers, M., Morrison, M., Salic, K., Stoop, R., Turner, S.M., Li, K., Beysen, C., Hanauer, G., van den Hoek, A.M., Kleemann, R., Hanemaaijer, R.

Get full text

PS16 - 80. VLDL-lowering effects of metformin in APOE3-Leiden.CETP mice, a transgenic model for human-like lipoprotein metabolism by Guigas, B., Geerling, J.J., van der Zon, G.C.M., van den Hoek, A.M., Princen, H.M.G., Havekes, L.M., Rensen, P.C.N.

Get full text

Lipidomics reveals multiple pathway effects of a multi components preparation on lipd biochemistry in ApoeE3Leiden.CETP mice by Wei, H, Hu, C, Wang, M, Hoek, A.M., van den, Reijmers, T.H, Wopereis, S, Bouwman, J, Ramaker, R, Korthout, H.A.A.J, Vennik, M, Hankemeier, T, Havekes, L.M, Witkamp, R.F, Verheij, E.R, Xu, G, Greef, J., de

“…Background: Causes and consequences of the complex changes in lipids occurring in the metabolic syndrome are only partly understood. Several interconnected…”
Get full text

244 APOE3LEIDEN.CETP TRANSGENIC MICE AS MODEL FOR THE METABOLIC SYNDROME by van den Hoek, A.M., van der Hoorn, J.W.A., Maas, M.C.E., van den Hoogen, C.M., van Nieuwkoop, A., Offerman, E.O., Pieterman, E.J., Havekes, L.M., Princen, H.M.G.

Get full text

P328 APOE3LEIDEN.CETP TRANSGENIC MICE AS MODEL FOR THE METABOLIC SYNDROME by van der Hoorn, J.W.A., van den Hoek, A.M., Maas, A.C., van den Hoogen, R.M., van Nieuwkoop, A., Offerman, E.O., Havekes, L.M., Princen, H.M.

Get full text

PO4-98 PERFLUOROHEXANESULFONATE AND PERFLUOROOCTANESULFONATE DECREASE PLASMA CHOLESTEROL AND TRIGLYCERIDES IN APOE3LEIDEN TRANSGENIC MICE. INDICATION FOR A PPARα AGONIST MECHANISM by Pieterman, E., van den Hoek, A.M., Havekes, L.M., Ehresman, D.J., Chang, S., Butenhoff, J.L., Princen, H.M., Cohen, L.H.

Get full text